Early trials and First-in-Man in mitral valve replacement

Session comprising selected EuroPCR 2019 Late-Breaking Trial submissions

Chairpersons: J. Bax, G. Nickenig
Panellists: S. Berti, H. Ince
SHOW MORE

Summary

Consult this session to learn more about the latest first-in man trials in mitral valve replacement: Tendyne MAC study, MITRAL trial, TIARA-I & TIARA-II, and more!

Presentations available when logged in:

  • Mitral regurgitation severity predicts one-year therapeutic benefit of Tendyne transcatheter mitral valve implantation
  • Transcatheter mitral valve implantation in patients with severe mitral annular calcification: early results from the Tendyne MAC study
  • One-year outcomes of transcatheter mitral valve-in-valve, valve-in-ring and valve-in-mitral annular calcification: results from the MITRAL trial
  • Early feasibility study of the Cardiovalve transfemoral mitral valve system
  • Innovative design of a transcatheter transapical mitral valve and update on Tiara I and Tiara II clinical data